# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4826115 | Functional | Antibacterial activity against Escherichia coli at 20 ug/ml | Escherichia coli | 4 | ALA4825664 | organism-based format | Scientific Literature | |
2. | ALA4826116 | Functional | Antibacterial activity against Staphylococcus aureus at 20 ug/ml | Staphylococcus aureus | 4 | ALA4825664 | organism-based format | Scientific Literature | |
3. | ALA4826117 | Functional | Antiviral activity against Influenza virus H1N1 at 100 uM | Influenza A virus | 4 | ALA4825664 | organism-based format | Scientific Literature | |
4. | ALA4826118 | Functional | Antibacterial activity against Pseudomonas aeruginosa at 20 ug/ml | Pseudomonas aeruginosa | 4 | ALA4825664 | organism-based format | Scientific Literature | |
5. | ALA4826119 | Functional | Antifungal activity against Candida albicans at 20 ug/ml | Candida albicans | 4 | ALA4825664 | organism-based format | Scientific Literature | |
6. | ALA4826124 | ADME | Drug metabolism in MeOH solution assessed as (+)-17-Hydroxybrevianamide N formation measured after 4 days by HPLC analysis | 1 | ALA4825664 | assay format | Scientific Literature | ||
7. | ALA4826125 | ADME | Drug metabolism in MeOH solution with 0.01% KOH assessed as (+)-17-Hydroxybrevianamide N formation measured after 4 days by HPLC analysis | 1 | ALA4825664 | assay format | Scientific Literature | ||
8. | ALA4826126 | ADME | Drug metabolism in MeOH solution with 10% acetic acid assessed as (+)-17-Hydroxybrevianamide N formation measured after 4 days by HPLC analysis | 1 | ALA4825664 | assay format | Scientific Literature | ||
9. | ALA4826127 | ADME | Drug metabolism in MeOH solution with 2% TFA assessed as (+)-17-Hydroxybrevianamide N formation measured after 4 days by HPLC analysis | 1 | ALA4825664 | assay format | Scientific Literature |